2 completed, 1 not yet recruiting, 1 terminated. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Philippe Bégin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Sucrose and Cold Oral Interventions for the Treatment of Oral Pruritus During Allergy Procedures. Food (sucrose), Food (popsicle), Food(Sucrose and cold) - Allergy, Food Allergies | Not applicable | Not yet recruiting | Philippe Bégin | 48 | 2026-11-01 | 2026-11-04 |
| INhaled Salbutamol vs Placebo for the Treatment of Acute IgE-mediated Abdominal Pain From Allergic Food REactions Salbutamol, Placebo - IgE-mediated Abdominal Pain | Phase 3 | Terminated | Philippe Bégin | 24 | 2023-07-01 | 2025-05-21 |
| Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy Abatacept, Placebo, Peanut oral immunotherapy - Peanut Allergy | Phase 2 | Completed | Philippe Bégin | 14 | 2022-03-01 | 2024-11-27 |
| Omalizumab to Accelerate a Symptom-driven Multi-food OIT Omalizumab 16mg/kg, Omalizumab 8mg/kg, Placebo - Food IgE-mediated Allergy, Immunotherapy | Phase 2 | Completed | Philippe Bégin | 90 | 2019-11-11 | 2026-11-04 |
Food Hypersensitivity (2) · Anaphylaxis (1) · Environmental Illness (1) · Hypersensitivity (1) · Peanut Hypersensitivity (1)
Abatacept (1) · Albuterol (1) · Cold Temperature (1) · Food (1) · Omalizumab (1) · Sucrose (1) · Water (1)
Canada (4)